Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’d say 80% of diabetics are going to turn to this new strain. And it’s legal .,,,,We have a monster stock in the making
OTC stock of the year and next year,,,, everyone in OTC land knows about this or soon will.
I would like to thank all the management team of SSOF for leaving us with this gift....
Not a pump ..it’s real ..that’s why it keeps going up,,,,You best get in
Check out the weekly and monthly chart.
https://finance.yahoo.com/quote/SSOF/news/
Lot’s of big names in this one
Maybe they need money to get FDA approval. They already have the recommendation to do so from the FDA. Hence the 300 million extra shares which would give them around $700,000.This stock is headed upwards
Don’t think anybody would be lying about the FDA and a recommendation to seek approval ....I think you’d be in serious trouble if you did.
ABOUT ZIMMERMAN BIOPHARMACEUTICALS, INC.
Zimmerman BioPharmaceuticals, Inc, is a biopharmaceutical company that owns a patent-protected process that will deliver biosimilar alternatives to biologic medicines at a lower cost to consumers. Its process lowers production costs, improves product cycle time, and delivers greater product stability. Zimmerman’s products have been fully validated in pre-clinical trials and testing, and has an FDA recommendation to seek approval through an accelerated process.
Excellent..699 million... great for an OTC stock
In answer to the lawyer part. You asked “why would all these different companies have the same lawyer”. If this lawyer was dishonest I don’t think Zimmerman would be involved
Smart people buying. Huge names here and more to come
Stock of the year....Millionaires will be made
As people get older they get nicer..,,Maybe the old management is finally going to do something good for us
$500 gives you 250,000 shares. Anybody not getting into this is crazy....The downside is so minimal and the upside unlimited.....Zimmerman is completely legit...,Who cares if anyone is left from ssof
Looking good ssof...2’s or more tomorrow
A shell can be bought
With a drug like this and a small float you’re talking dollars not pennies
It just happened. Give it a few days and news about it will be out
You’ll know you’re wrong in the next few days
Fluff news every other day. No fluff news in my books
A slow grinding 10 bagger ....Perfect as that means it’s not a pump and dump and would go much higher
It’s written right there folks...Do you think all the people involved want to go to jail
Just sent a message to:
Zimmerman BioPharmaceuticals, Inc.
info@zbpinc.com
www. zbpinc.com
Asking for an update.
I thank Jim for what he’s done for ssof shareholders....Brilliant plan. As he could’ve left us to dry
Shouldn’t be long. ...When it does this is going to rocket
In one phone call I remember Jim saying to me “why are you invested” I said “because I want to make money.” He didn’t say anything......But he did go on to talk to me for another 5 or 6 minutes...Seemed like a really nice guy who uses the system legally to make money...
In answer to your question ..I’d say there’s going to be lots of changes to the better
SSOF PROFILE DATA
SIC - Industry Classification
2834 - Pharmaceutical preparations
..,,,That looks great on their website..,,
I’m definitely ready to be a millionnaire
Are you on board mick
Old management out. New management in. People are now saying that the Zimmermans are crooks to.,,, ya sure
Yes, huge potential here. Good luck to you
Chance to become a millionnaire here
Doesn’t get better than this read :
Mr. David Wood leads Zimmerman BioPharmaceuticals as President and CEO with 35+ years experience as an operations executive in start-ups and Fortune 25 companies; delivering rapid revenue growth, and building teams to sustain growth & profitability. He was the CRO for Scient Inc., VP & GM for the $180 million Enterprise BU, and the President & COO for The Joseph Company valued at $40 million. He served as a Captain in the United States Army, and holds a Bachelor of Science, Magna Cum Laude, from Northeastern University.
Mr. Jim Frazier, the previous CEO of 665 Energy Inc., has tendered his resignation and controlling interest of the company effective immediately.
Beverage company ....CBD beverages
And the next thing you’re going to find out is that everything is legit
FOR IMMEDIATE RELEASE
Six Six Five Energy, Inc.
Announce acquisition of Zimmerman Biopharmaceuticals and intent to spin off Maxwell Exploration
OKLAHOMA CITY Six Six Five Energy, Inc. (OTC: SSOF) announces that it has acquired Zimmerman Biopharmaceuticals, Inc. and is spinning off its wholly owned subsidiary, Maxwell Exploration LLC, which plans to form its own public oil and gas resource company. [See Zimmerman Press Release for more detail on Zimmerman].
“The acquisition of Zimmerman is a new direction for SSOF and gives shareholders and investors an opportunity to participate in a growing company that has market critical products. Additionally, with the spin-off of Maxwell, existing shareholders will have an interest in Maxwell Exploration as it continues to grow by continuing to acquire and develop oil and gas assets. I know and expect that Mr. David Wood will bring real success to SSOF as he has Zimmerman and Mr. John Johnson will continue to do the same for Maxwell as each company President begins a new direction”, said Jim Frazier, former President and CEO.
About Six Six Five Energy, Inc.
Six Six Five Energy is an Energy and Resource holding company. For more information, visit
www.665Energy.com
SSOF...0015...Merger Acquisition news...Zimmerman BioPharmaceuticals has invested more than 7 years and $6 million in developing
and patenting this process. Zimmerman’s biosimilar insulin has been fully validated in preclinical trials and testing. The company has received an FDA recommendation to seek approval
through the accelerated 505(b)(2) NDA process.
Dr. Ron Zimmerman is the Founder and Chief Science Officer of Zimmerman
BioPharmaceuticals. Dr. Zimmerman served as the Chief Scientist at Eli Lilly for more than 30 years.
https://backend.otcmarkets.com/otcapi/company/dns/news/document/38779/content
OKLAHOMA CITY Six Six Five Energy, Inc. (OTC: SSOF) announces that it has acquired
Zimmerman Biopharmaceuticals, Inc. and is spinning off its wholly owned subsidiary, Maxwell
Exploration LLC, which plans to form its own public oil and gas resource company. [See
Zimmerman Press Release for more detail on Zimmerman].
https://backend.otcmarkets.com/otcapi/company/dns/news/document/38778/content
I told you guys news was coming. And I’m telling you that there’s more to come very shortly